Insulet Corp Files 8-K on Officer Changes and Shareholder Votes

TL;DR

Insulet filed an 8-K covering exec changes, director elections, and shareholder votes.

AI Summary

On May 22, 2025, Insulet Corporation filed an 8-K report detailing several key events. The filing includes information regarding the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. Additionally, it covers the submission of matters to a vote of security holders and the filing of financial statements and exhibits.

Why It Matters

This filing provides crucial updates on Insulet's corporate governance and executive appointments, which can impact investor confidence and strategic direction.

Risk Assessment

Risk Level: low — The filing reports routine corporate governance matters and does not indicate any immediate financial distress or significant operational changes.

Key Players & Entities

• Insulet Corporation (company) — Registrant
• Delaware (jurisdiction) — State of incorporation
• 001-33462 (company_id) — SEC File Number
• 04-3523891 (company_id) — IRS Employer Identification No.
• 100 Nagog Park (address) — Principal executive offices
• Acton (city) — Principal executive offices
• Massachusetts (state) — Principal executive offices
• 01720 (zip_code) — Principal executive offices
• (978) 600-7000 (phone_number) — Registrant's telephone number
• May 22, 2025 (date) — Date of earliest event reported

FAQ

From the Filing

0001145197-25-000030.txt : 20250528 0001145197-25-000030.hdr.sgml : 20250528 20250528161116 ACCESSION NUMBER: 0001145197-25-000030 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20250522 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250528 DATE AS OF CHANGE: 20250528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 25995533 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K 1 podd-20250522.htm 8-K podd-20250522 0001145197 FALSE 0001145197 2025-05-22 2025-05-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):  May 22, 2025   INSULET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-33462 04-3523891 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 100 Nagog Park Acton Massachusetts 01720 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (978) 600-7000 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 Par Value Per Share PODD The NASDAQ Stock Market, LLC Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Approval of 2025 Annual Stock Option and Incentive Plan. As described in Item 5.07 below, at the 2025 annual meeting of shareholders (the “2025 Annual Meeting”) of Insulet Corporation (the “Company”) held on May 22, 2025, the Company’s shareholders approved the Insulet Corporation 2025 Stock Option and Incentive Plan (the “2025 Plan”) to replace the Insulet Corporation 2017 Stock Option and Incentive Plan as a means by which the Company makes equity and cash awards t